期刊文献+

肺表面活性物质对急性肺损伤大鼠生存率的影响 被引量:3

Effect of pulmonary surfactant on survival rate of the rats with acute lung injury
原文传递
导出
摘要 目的观察急性肺损伤(ALI)大鼠早期补充肺表面活性物质(PS)对大鼠生存率的影响。方法建立细菌感染导致肺内源性ALI动物模型,并分两步进行:(1)建立大鼠ALI模型,经气管滴入大肠杆菌液[3ml/kg,(4.4-5.6)×10^9 CFU/ml],动态观察72h大鼠病情演变(n=24)和模型稳定性;并将100h划分为5个连续时间段:第1时间段(正常大鼠,n=11),第2~5时间段分别为感染后0~6h(n=10)、7~18h(n=14)、19~52h(n=87)、53-100h(n=34),观察机械通气15min(n=156)后血气、胸肺有效动态顺应性、肺病理改变情况。(2)大鼠感染后3~6h,PS组(n=16)和NS(n=16)组分别经气管滴入肺表面活性物质或生理盐水,观察生存率。结果(1)本模型较稳定,PaO2/FiO2可从正常(533±16)mmHg(1mmHg=0.133kPa)降到(175±121)mmHg。在第4时间段肺大体标本呈现明显肝样变和弥漫性出血、坏死灶;肺组织切片见肺泡壁明显水肿,大量炎症细胞浸润,严重实变、肺透明膜形成。(2)PS组生存率(26.7%)较NS组(12.5%)明显提高(Log Rank P=0.014,Breslow P=0.0028)。结论在ALI早期补充PS可以延长大肠杆菌致肺内源性ALI大鼠生存时间,提高生存率。 Objective To investigate the effect of pulmonary surfactant supplement on the survival of rats with acute lung injury (ALI)/ARDS during the early stage. Methods We devided the procedure to establish the ALI/ARDS rat mode/infected by Escherichia coli (E. coli) into two sections. Section 1 : We established an ALI/ARDS rat mode/ through transtracheal application with 3 rnl/kg E. coli of suspended fluid [ (4.4 - 5.6) × 10^9 CFU·ml^-1 ]. First, the disease progress of infected rats for 72 hours ( n = 24 ) and the model stability was observed. Second, we divided the following 100 h into five time segments (n = 156). The 1st time segment (healthy rats, n = 11 ), the 2nd time segment to the 5th time segment was respectively during infected 0- 6 h ( n = 10), 7- 18 h ( n = 14), 19 - 52 h ( n = 87), 53 - 100 h ( n = 34). Peak inspiratory pressures (PIP), tidal volumes (Vt), dynamic lung-thorax compliance (Cdyn), and blcod gas determinations ( PaO2, PaCO2, pH) were recorded after ventilation for 15 minutes under the protocol. Then left lungs morphological observation of three rats in each segment were done to inspect the disease. Section 2 : survival rates were determined at 72 h for the group PS [n = 16, 1.25 ml/kg CurosurfR(80 mg/ml)] and group NS (n = 16). Results (1) The rat mode/could be repeated well. PaO2/FiO2 was decreased from normal (533 ± 16) mm Hg to (175 ± 121) mm Hg. At the 4th time segment the infected lungs became hepatized obviously with profuse hemorrhage and necrosis. Under the microscope, a lot of effusion and obvious edema in alveolar wall, granuloeyrie infiltrates in alveoli and interstitia, severe alveolar atelectasis, hyaline membranes m many areas could be seen. (2) The survival rate in group PS (26.7%) was signifficant higher than that in group NS (12.5%) (Log Rank P = 0. 014, Breslow P = 0.002 8). Conclusion It suggests that supplementary PS at the early stage of ALI can prolong survival time and improve survival rate of the model rats.
出处 《中国小儿急救医学》 CAS 2008年第1期51-54,F0003,共5页 Chinese Pediatric Emergency Medicine
基金 国家科技攻关计划资助项目(2003BA712A11-10)
关键词 急性肺损伤 肺表面活性物质 生存率 Acute lung injury Pulmonary surfactant Survival rate
  • 相关文献

参考文献3

二级参考文献22

  • 1中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203.
  • 2Puligandla PS, Gill T, Mc cail LA, et al. Alreolar en riroment in fluemces the metabolic and biophysical properties of erogenous surfactants. J Appl Physiol, 2000, 88 (3) : 1061 - 1071.
  • 3Song GW, Robertson B, Curstedt T, et al. Surfactant treatment in experimental Escherichia coli pneumonia. Acta Anaesthesiol Scand,1996, 40(9) : 1154 - 1160.
  • 4Rauprich P, Moiler O, Walter G, et al. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period. Clin Diagn Lab Immunol, 2000, 7 (5) : 817 - 822.
  • 5Schmidt R, Meier U, Yabut-Perez M, et al. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med, 2001, 163 (1) : 95 - 100.
  • 6Lewis J F, Jobe A H. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis, 1993, 147 (1) : 218 - 233.
  • 7Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome, J Pathol, 2004,202 (2) : 145 - 156.
  • 8Ashbaugh DG;Bigelow DB;Petty L.Acute respiratory ditress in adults[J],1967.
  • 9Bernard GR;Artigas A;Brigham KL.and the consensus committee The American-European Consensus Conference on ARDS,definitions,mechanisms,relevant outcomes,and clinical trial coordination,1994.
  • 10Artigas A;Bernard GR;Carlet J.The American-European Consensus Conference on ARDS,part2:ventilatory,pharmacologic,supportive therapy,study design strategies,and issues related to recovery and remodeling,1998.

共引文献72

同被引文献43

  • 1刘雪雁,薛辛东.高氧致慢性肺疾病新生大鼠肺组织尿激酶型纤溶酶原激活因子和纤溶酶原激活物抑制因子1表达的动态改变及意义[J].中华儿科杂志,2008,46(6):458-463. 被引量:2
  • 2喻文亮,陆铸今,王莹,施丽萍,匡凤梧,张剑晖,谢敏慧,钱素云,樊寻梅,孙波.小儿急性呼吸窘迫综合征前瞻性多中心临床流行病学研究[J].中华急诊医学杂志,2005,14(6):448-453. 被引量:57
  • 3舒林华,薛辛东,舒林宏,刘春峰,吴红敏,韩晓华,尚云晓,蔡栩栩,许巍,魏克伦.脂多糖诱导的急性肺损伤幼鼠肺泡Ⅱ型上皮细胞超微结构研究[J].国际儿科学杂志,2007,34(3):166-168. 被引量:8
  • 4Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based suffactant on the acute respiratory distress syndrome. N Engl J Med,2004 ,351:884-892.
  • 5Friedrich W, Schmalisch G, Stevens PA, et al. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins. Eur J Med Res,2000,5:277-282.
  • 6Alves-Filho JC, de Freitas A, Spiller F, et al. The role of neutrophils in severe sepsis. Shock,2008,30(7) :3-9.
  • 7Laffey JG, Tanaka M, Engelberts D, et al. Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care IVied. ,2000,162 (6) :2287-2294.
  • 8Chuang IC, Dong HP, Yang RC, et al. Effect of carbon dioxide on pulmonary vascular tone at various pulmonary arterial pressure levels induced by endothelin-1. Lung,2010,188 (3) : 199-207.
  • 9Wang N, Gates KL, Trejo H, et al. Elevated CO2 selectively inhibits interleuldn-6 and tumor necrosis factor expression and decreases phagoeytosis in the macrophage. FASEB J, 2010, 24 ( 7 ) : 2178- 2190.
  • 10Doerr CH, Gajic O, Berrios JC, et al. Hypercapnic acidosis impairs plasma membrane wound resealing in ventilator-injured lungs. Am J Respir Crit Care Med,2005,171 (12) :1371-1377.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部